Authored By: Sarah
05 Dec 2024

Latest News- Stem Cell Manufacturing Market: Hospitals and surgical centres is expected to lead the Deployment segment during 2024-2028

The Stem Cell Manufacturing Market is being driven by Rising prevalence of several chronic disorders

The Stem Cell Manufacturing Market is expected to grow at a CAGR of 9.3% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 6433.8 million. In the realm of personalized medicine, mesenchymal stem cells (MSCs) are gaining significant attention due to their potential to deliver treatments tailored to individual patients' characteristics, needs, and preferences. MSCs, which are located in the vascular region of bone marrow, offer several advantages over traditional treatments. These advantages include a reduced risk of immune rejection, eliminating the need for embryonic stem cells, minimal requirement for anti-rejection drugs, and a lower risk of graft rejection. Moreover, MSCs have a lower likelihood of inducing graft-versus-host disease (GvHD), a common complication of immunosuppressive therapy for hematological malignancies and solid tumors. Despite the necessity of immunosuppressive therapy for treating these conditions, its side effects often outweigh its therapeutic benefits. Consequently, the research and development community is intensely investigating methods to harness the benefits of MSCs for personalized medicine applications. 

Get more information on Stem Cell Manufacturing Market by requesting a sample report

 

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on Deployment (Hospitals and surgical centres, Cell and tissue banks, Others, P and BC, AI RL and CRO) Geography (North America, Europe, Asia, Rest of World (ROW)). 

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

  • Rising prevalence of several chronic disorders
  • Rising focus on regenerative medicines
  • Increased federal investment in stem cell therapy

Benefits of Buying Global Stem Cell Manufacturing Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Key Features in Stem Cell Manufacturing Market Research Report

  • Comprehensive Market Analysis
  • In-Depth Competitive Landscape
  • Future Market Trends
  • Detailed Market Segmentation.
  • Expert Analysis, and more...

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Stem Cell Manufacturing Market is a significant segment of the healthcare industry, driven by regulatory policies and scientific discoveries in stem cell research. Investors are increasingly interested in this field due to its potential for regenerative medicine therapies and treatments for various diseases and injuries, including neurodegenerative disorders like Amyotrophic Lateral Sclerosis and Alzheimer's disease, heart disease, organ failure, and cancer. Operational costs, sterility, skilled workforce, and environmental factors are key challenges. Therapies for spinal cord injuries, Parkinson's disease, stroke, osteoarthritis, and corneal diseases are in development. Temperature control is crucial for maintaining the efficacy of these delicate cells.

Market Research Overview

The Stem Cell Manufacturing Market is a significant segment within the broader healthcare industry, encompassing businesses involved in research and development (R&D) or production of stem cell-related products. According to Technavio's market analysis, the global healthcare market size is determined by the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the global pharmaceuticals market will be fueled by several key factors, including an aging population. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to be over 60 years old. This demographic shift will increase the demand for regenerative medicine solutions, including those for neurodegenerative disorders, heart disease, and organ failure. Investors are taking notice of this trend, injecting capital into stem cell research and development. However, operational costs, such as sterility and the need for a skilled workforce, pose challenges to market growth. Regulatory policies also play a crucial role in shaping the market landscape.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.